tert-Butyl (5-bromothiazol-2-yl)carbamate

Catalog No. :
ACTSCF518
CAS No. :
405939-39-1
Molecular Formula :
C8H11BrN2O2S
Molecular Weight :
279.16

IUPAC Name:tert-butyl (5-bromothiazol-2-yl)carbamate

tert-Butyl (5-bromothiazol-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$56.00Login to see priceIn stockIn stock
100g97%$195.00Login to see priceIn stockIn stock
500g97%$946.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (5-bromothiazol-2-yl)carbamate
IUPAC Nametert-butyl (5-bromothiazol-2-yl)carbamate
MDL No.MFCD07368614
Molecular FormulaC8H11BrN2O2S
Molecular Weight279.16
SMILESBrC1=CN=C(NC(OC(C)(C)C)=O)S1
InChI KeyOIBKBVFFZYCBAQ-UHFFFAOYSA-N
SynonymN-Boc-2-Amino-5-bromothiazole | tert-butyl 5-bromothiazol-2-ylcarbamate | tert-Butyl (5-bromothiazol-2-yl)carbamate | (5-BROMO-THIAZOL-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER | tert-butyl N-(5-bromo-1,3-thiazol-2-yl)carbamate | MFCD07368614
CAS No.405939-39-1
PubChem CID21300388

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACTSCF518 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGLFX394 route compound structure diagram
    ACGLFX394133692-18-9 In Stock
  4. Then
  5. ACTSCF518 route product structure diagram
    ACTSCF518405939-39-1 In Stock
Inquiry

2. ACTSCF518 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEQFU321 route compound structure diagram
    ACEQFU321170961-15-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTSCF518 route product structure diagram
    ACTSCF518405939-39-1 In Stock
Inquiry

Comments (0)